Medication discontinuation: Difference between revisions
Content deleted Content added
Organized. Added potential effects |
m Moving from Category:Clinical pharmacology to Category:Prescription of drugs using Cat-a-lot |
||
| (66 intermediate revisions by 29 users not shown) | |||
| Line 1: | Line 1: | ||
{{short description|Ceasing of a medication treatment for a patient}} |
|||
{{Unreferenced stub|auto=yes|date=December 2009}} |
|||
{{ |
{{redirect|Discontinuation|the discontinuation of products|End-of-life (product)}} |
||
'''Medication discontinuation''' is the ceasing of a [[medication]] treatment for a patient by either the [[clinician]] or the patient themself.<ref name="Raebel 2013">{{cite journal | vauthors = Raebel MA, Schmittdiel J, Karter AJ, Konieczny JL, Steiner JF | title = Standardizing terminology and definitions of medication adherence and persistence in research employing electronic databases | journal = Medical Care | volume = 51 | issue = 8 Suppl 3 | pages = S11-21 | date = August 2013 | pmid = 23774515 | pmc = 3727405 | doi = 10.1097/MLR.0b013e31829b1d2a }}</ref><ref name="Abdullah-Koolmees 2015">{{cite journal | vauthors = Abdullah-Koolmees H, Gardarsdottir H, Yazir D, Stoker LJ, Vuyk J, Egberts TC, Heerdink ER | title = Medication Discontinuation in Patients After Discharge From a Psychiatric Hospital | journal = The Annals of Pharmacotherapy | volume = 49 | issue = 10 | pages = 1085–95 | date = October 2015 | pmid = 26160969 | doi = 10.1177/1060028015593763 | hdl = 1874/329744 | s2cid = 19123557 | hdl-access = free }}</ref> When initiated by the clinician, it is known as [[deprescribing]].<ref name=LINSKY2017 /> Medication discontinuation is an important medical practice that may be motivated by a number of reasons:<ref>{{cite journal | vauthors = Nixon M, Kousgaard MB | title = Organising medication discontinuation: a qualitative study exploring the views of general practitioners toward discontinuing statins | journal = BMC Health Services Research | volume = 16 | issue = 1 | pages = 226 | date = July 2016 | pmid = 27388025 | pmc = 4936268 | doi = 10.1186/s12913-016-1495-2 | doi-access = free }}</ref><ref name=LINSKY2017>{{cite journal | vauthors = Linsky A, Meterko M, Stolzmann K, Simon SR | title = Supporting medication discontinuation: provider preferences for interventions to facilitate deprescribing | journal = BMC Health Services Research | volume = 17 | issue = 1 | pages = 447 | date = June 2017 | pmid = 28659157 | pmc = 5490086 | doi = 10.1186/s12913-017-2391-0 | doi-access = free }}</ref> |
|||
'''Discontinuation''' is the process of quitting a procedure, such as, the course of treatment with a drug or a consumer product line. |
|||
* Reducing [[polypharmacy]] |
|||
* Reducing [[health expenditure]] |
|||
* Improving [[quality of life]] by ceasing medications with potential [[adverse effects]] or where the [[Indication (medicine)|indication]] for a medical treatment may have changed |
|||
* Reflect changes in [[evidence based medicine|evidence]] that support a treatment |
|||
* Reflecting changes in treatment goals, such as a move to [[end-of-life care]].<ref name="ABEL2013">{{cite journal | vauthors = Abel J |title=Withdrawing life-extending drugs at the end of life |journal=Prescriber |date=July 2013 |volume=24 |issue=13–16 |pages=17–20 |doi=10.1002/psb.1083|doi-access= }}</ref> |
|||
Unlike the prescribing of medications, appropriate discontinuation has not attracted nearly as much attention or interest.<ref>{{cite journal | vauthors = Bain KT, Holmes HM, Beers MH, Maio V, Handler SM, Pauker SG | title = Discontinuing medications: a novel approach for revising the prescribing stage of the medication-use process | journal = Journal of the American Geriatrics Society | volume = 56 | issue = 10 | pages = 1946–52 | date = October 2008 | pmid = 18771457 | pmc = 3119470 | doi = 10.1111/j.1532-5415.2008.01916.x }}</ref> |
|||
==Drugs== |
|||
*Discontinuation of a treatment is to stop taking a drug. There are several reasons for discontinuation, e.g.: |
|||
**The ailment or reason it was taken has disappeared. |
|||
**The [[adverse effects]] outweigh the desired effects. |
|||
**Other, better, alternatives are available. |
|||
==End-of-life care== |
|||
| ⚫ | |||
Medications may be stopped in the context of [[end-of-life care]], such as medications that may affect [[risk factor]]s for future disease. Medications that may be stopped as part of discussions about end-of-life care include [[antihypertensives]], medications for [[diabetes]], and drugs for [[hypercholesterolemia|high cholesterol]].<ref name=ABEL2013 /> |
|||
==Life limiting conditions== |
|||
==Consumer products== |
|||
For people with a life limiting condition such as a dementia, it is important to consider when to discontinue medications used to prevent future serious events. The [[MATCH-D|Medication Appropriateness Tool for Comorbid Health conditions during Dementia]] ([http://MATCH-D.com.au MATCH-D]) provides guidance for clinicians and consumers on how to manage medications.<ref>{{cite journal | vauthors = Page AT, Potter K, Clifford R, McLachlan AJ, Etherton-Beer C | title = Medication appropriateness tool for co-morbid health conditions in dementia: consensus recommendations from a multidisciplinary expert panel | journal = Internal Medicine Journal | volume = 46 | issue = 10 | pages = 1189–1197 | date = October 2016 | pmid = 27527376 | pmc = 5129475 | doi = 10.1111/imj.13215 }}</ref> |
|||
*Discontinuation for consumer products is when a [[product (business)|product]]'s manufacture and/or support are stopped by the [[company]] that makes the product. This is usually due to low sales, but it does not mean the product never sold well. Many high selling products eventually see a drop in sales and eventual discontinuation, usually after being superseded by a superior product. |
|||
== |
==Effects== |
||
| ⚫ | |||
*[[Out of print]] |
|||
| ⚫ | |||
Drug discontinuation may be difficult to adjust to, owing to the long term use and the symbolism associated with ceasing medications, such as the decision to stop [[chemotherapy]].<ref name=ABEL2013 /> |
|||
| ⚫ | |||
Recent research (Nixon & Vendelø, 2016) shows that General Practitioners (GPs) who actively consider discontinuation, are reluctant to do so, as they experience that the safest decision is to continue prescriptions, rather than discontinue them. In part this is due to the ambiguity about the appropriateness of discontinuing medication. The clinical guidelines available to GPs do not encourage discontinuation of medication, and thus, they offer GPs a weak frame for discontinuation. |
|||
=== Anti-hypertensive drugs === |
|||
{{Business-stub}} |
|||
'''Withdrawal of anti-hypertensive drugs in older people''' |
|||
{{Medicine-stub}} |
|||
The latest evidence does not have evidence of an effect due to discontinuing vs continuing medications used for treating elevated blood pressure or prevention of heart disease in older adults on all-case mortality and incidence of heart attack.<ref name=":1">{{cite journal | vauthors = Reeve E, Jordan V, Thompson W, Sawan M, Todd A, Gammie TM, Hopper I, Hilmer SN, Gnjidic D | display-authors = 6 | title = Withdrawal of antihypertensive drugs in older people | journal = The Cochrane Database of Systematic Reviews | volume = 2020 | pages = CD012572 | date = June 2020 | issue = 6 | pmid = 32519776 | pmc = 7387859 | doi = 10.1002/14651858.cd012572.pub2 }}</ref> The findings are based on low quality evidence suggesting it may be safe to stop anti-hypertensive medications. However, older adults should not stop any of their medications without talking to a healthcare professional.<ref name=":1" /> |
|||
== See also == |
|||
*[[Deprescribing]] |
|||
*[[Withdrawal syndrome]] |
|||
| ⚫ | |||
== References == |
|||
{{reflist|30em}} |
|||
{{Unnecessary health care}} |
|||
[[Category:Prescription of drugs]] |
|||
| ⚫ | |||
[[Category:Pharmaceuticals policy]] |
|||
Latest revision as of 03:07, 9 December 2023
Medication discontinuation is the ceasing of a medication treatment for a patient by either the clinician or the patient themself.[1][2] When initiated by the clinician, it is known as deprescribing.[3] Medication discontinuation is an important medical practice that may be motivated by a number of reasons:[4][3]
- Reducing polypharmacy
- Reducing health expenditure
- Improving quality of life by ceasing medications with potential adverse effects or where the indication for a medical treatment may have changed
- Reflect changes in evidence that support a treatment
- Reflecting changes in treatment goals, such as a move to end-of-life care.[5]
Unlike the prescribing of medications, appropriate discontinuation has not attracted nearly as much attention or interest.[6]
End-of-life care[edit]
Medications may be stopped in the context of end-of-life care, such as medications that may affect risk factors for future disease. Medications that may be stopped as part of discussions about end-of-life care include antihypertensives, medications for diabetes, and drugs for high cholesterol.[5]
Life limiting conditions[edit]
For people with a life limiting condition such as a dementia, it is important to consider when to discontinue medications used to prevent future serious events. The Medication Appropriateness Tool for Comorbid Health conditions during Dementia (MATCH-D) provides guidance for clinicians and consumers on how to manage medications.[7]
Effects[edit]
Drug discontinuation may cause rebound effects (return of the symptoms the drug relieved, and that, to a degree stronger than they were before treatment first began) and withdrawal syndromes (symptoms caused by the discontinuation by the drug itself).
Drug discontinuation may be difficult to adjust to, owing to the long term use and the symbolism associated with ceasing medications, such as the decision to stop chemotherapy.[5]
Recent research (Nixon & Vendelø, 2016) shows that General Practitioners (GPs) who actively consider discontinuation, are reluctant to do so, as they experience that the safest decision is to continue prescriptions, rather than discontinue them. In part this is due to the ambiguity about the appropriateness of discontinuing medication. The clinical guidelines available to GPs do not encourage discontinuation of medication, and thus, they offer GPs a weak frame for discontinuation.
Anti-hypertensive drugs[edit]
Withdrawal of anti-hypertensive drugs in older people
The latest evidence does not have evidence of an effect due to discontinuing vs continuing medications used for treating elevated blood pressure or prevention of heart disease in older adults on all-case mortality and incidence of heart attack.[8] The findings are based on low quality evidence suggesting it may be safe to stop anti-hypertensive medications. However, older adults should not stop any of their medications without talking to a healthcare professional.[8]
See also[edit]
References[edit]
- ^ Raebel MA, Schmittdiel J, Karter AJ, Konieczny JL, Steiner JF (August 2013). "Standardizing terminology and definitions of medication adherence and persistence in research employing electronic databases". Medical Care. 51 (8 Suppl 3): S11-21. doi:10.1097/MLR.0b013e31829b1d2a. PMC 3727405. PMID 23774515.
- ^ Abdullah-Koolmees H, Gardarsdottir H, Yazir D, Stoker LJ, Vuyk J, Egberts TC, Heerdink ER (October 2015). "Medication Discontinuation in Patients After Discharge From a Psychiatric Hospital". The Annals of Pharmacotherapy. 49 (10): 1085–95. doi:10.1177/1060028015593763. hdl:1874/329744. PMID 26160969. S2CID 19123557.
- ^ a b Linsky A, Meterko M, Stolzmann K, Simon SR (June 2017). "Supporting medication discontinuation: provider preferences for interventions to facilitate deprescribing". BMC Health Services Research. 17 (1): 447. doi:10.1186/s12913-017-2391-0. PMC 5490086. PMID 28659157.
- ^ Nixon M, Kousgaard MB (July 2016). "Organising medication discontinuation: a qualitative study exploring the views of general practitioners toward discontinuing statins". BMC Health Services Research. 16 (1): 226. doi:10.1186/s12913-016-1495-2. PMC 4936268. PMID 27388025.
- ^ a b c Abel J (July 2013). "Withdrawing life-extending drugs at the end of life". Prescriber. 24 (13–16): 17–20. doi:10.1002/psb.1083.
- ^ Bain KT, Holmes HM, Beers MH, Maio V, Handler SM, Pauker SG (October 2008). "Discontinuing medications: a novel approach for revising the prescribing stage of the medication-use process". Journal of the American Geriatrics Society. 56 (10): 1946–52. doi:10.1111/j.1532-5415.2008.01916.x. PMC 3119470. PMID 18771457.
- ^ Page AT, Potter K, Clifford R, McLachlan AJ, Etherton-Beer C (October 2016). "Medication appropriateness tool for co-morbid health conditions in dementia: consensus recommendations from a multidisciplinary expert panel". Internal Medicine Journal. 46 (10): 1189–1197. doi:10.1111/imj.13215. PMC 5129475. PMID 27527376.
- ^ a b Reeve E, Jordan V, Thompson W, Sawan M, Todd A, Gammie TM, et al. (June 2020). "Withdrawal of antihypertensive drugs in older people". The Cochrane Database of Systematic Reviews. 2020 (6): CD012572. doi:10.1002/14651858.cd012572.pub2. PMC 7387859. PMID 32519776.